NCT00401661View on ClinicalTrials.gov

Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

PHASE4CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

December 31, 2007

Conditions

Prostatic Hyperplasia

Interventions

DRUG

Alfuzosin

One tablet of 10mg once daily at the end of evening meal

Trial Locations (1)

Unknown

Sanofi-Aventis, Bangkok

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY